Castle Biosciences to Release Second Quarter 2025 Financial Results and Host Conference Call on Monday, Aug. 4, 2025
Company management will host a conference call and webcast to discuss its financial results at 4:30 p.m. Eastern time on the same day.
Conference Call and Webcast DetailsA live webcast of the conference call can be accessed here: https://events.q4inc.com/attendee/164444215, or via the webcast link on the Investor Relations page of the Company's website: https://ir.castlebiosciences.com/overview/default.aspx. Please access the webcast at least 10 minutes before the conference call start time. A replay of the webcast will be available following the conclusion of the conference call.
To access the live conference call via phone, please dial 1 833 470 1428 from the United States, at least 10 minutes prior to the start of the call, using the access code 638217. International dial-in numbers are available here: https://www.netroadshow.com/conferencing/global-numbers?confId=84730; please use the same access code above to join the call.
There will be a brief Question and Answer session following management commentary.
About Castle BiosciencesCastle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.
Castle's current portfolio consists of tests for skin cancers, Barrett's esophagus and uveal melanoma. Additionally, the Company has active research and development programs for tests in these and other diseases with high clinical need, including its test in development to help guide systemic therapy selection for patients with moderate-to-severe atopic dermatitis seeking biologic treatment. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, X and Instagram.
DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, TissueCypher, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.
Investor Contact:Camilla Zuckeroczuckero@castlebiosciences.com
Media Contact:Allison Marshallamarshall@castlebiosciences.com
Source: Castle Biosciences Inc.Error al recuperar los datos
Inicia sesión para acceder a tu cartera de valores
Error al recuperar los datos
Error al recuperar los datos
Error al recuperar los datos
Error al recuperar los datos
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
9 minutes ago
- Associated Press
Tesla's Autopilot system is in the spotlight at a Miami trial over a student killed while stargazing
NEW YORK (AP) — A rare trial against Elon Musk's car company began Monday in Miami where a jury will decide if it is partly to blame for the death of a stargazing university student after a runaway Tesla sent her flying 75 feet through the air and severely injured her boyfriend. Lawyers for the plaintiff argue that Tesla's driver-assistance feature called Autopilot should have warned the driver and braked when his Model S sedan blew through flashing red lights, a stop sign and a T-intersection at nearly 70 miles an hour in the April 2019 crash. Tesla lays the blame solely on the driver, who was reaching for a dropped cell phone. 'The evidence clearly shows that this crash had nothing to do with Tesla's Autopilot technology,' Tesla said in a statement. 'Instead, like so many unfortunate accidents since cellphones were invented, this was caused by a distracted driver.' The driver, George McGee, was sued separately by the plaintiffs. That case was settled. A judgement against Tesla could be especially damaging as the company works to convince the public its self-driving technology is safe during a planned rollout of hundreds of thousands of Tesla robotaxis on U.S. roads by the end of next year. A jury trial is rare for the company, which often settles lawsuits, and this one is rarer yet because a judge recently ruled that the family of the stricken Naibel Benavides Leon can argue for punitive damages. The judge, Beth Bloom of the U.S. District Court for the Southern District of Florida, issued a partial summary judgement last month, throwing out charges of defective manufacturing and negligent misrepresentation against Tesla. But she also ruled plaintiffs could argue other claims that would make the company liable and ask for punitive damages, which could prove costly. 'A reasonable jury could find that Tesla acted in reckless disregard of human life for the sake of developing their product and maximizing profit,' Bloom said in a filing. The 2021 lawsuit alleges the driver relied on Autopilot to reduce speed or come to a stop when it detected objects in its way, including a parked Chevrolet Tahoe that Benavides and her boyfriend, Dillon Angulo, had gotten out of near Key West, Florida, to look up at the sky. The Tesla rammed the Tahoe at highway speeds, causing it to rotate and slam into Benavides, tossing her into a wooded area and killing her. In legal documents, Tesla denied nearly all of the lawsuit's allegations and said it expects that consumers will follow warnings in the vehicle and instructions in the owners' manual, as well as comply with driving laws. Tesla warns owners in manuals that its cars cannot drive themselves and they need to be ready to intervene at all times. —— Former AP auto writer Krisher reported from Detroit.
Wall Street Journal
12 minutes ago
- Wall Street Journal
The Benefit of Ebbing EVs
Helping Ukraine against a weakened Russia coincides nicely with the demise of electric vehicles, wind turbines and solar panels ('Trump Calls Out the Putin Charade,' Review and Outlook, July 9). Freed-up U.S. manufacturing capacity can go to missile systems and ammunition primarily for sale to Europe and use by Ukraine. General Motors has shown such versatility by producing tens of thousands of tanks and armored vehicles in World War II and 30,000 ventilators during the Covid pandemic. It's time to heed Rahm Emanuel's rule: You never want a serious crisis to go to waste. William J. Doyle
Bloomberg
15 minutes ago
- Bloomberg
China GDP, Bank Reports, US CPI, Fedspeak
Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Scarlet Fu, Norah Mulinda and Tim Stenovec. (Source: Bloomberg)
